• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哌嗪骨架在天然产物结构修饰中的应用:综述。

Piperazine skeleton in the structural modification of natural products: a review.

机构信息

College of Pharmacy, Yanbian University, Yanji, Jilin, 133002, China.

Affiliated Hospital of Yanbian University, Yanji, Jilin, China.

出版信息

J Enzyme Inhib Med Chem. 2021 Dec;36(1):1165-1197. doi: 10.1080/14756366.2021.1931861.

DOI:10.1080/14756366.2021.1931861
PMID:34080510
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8183565/
Abstract

Piperazine moiety is a cyclic molecule containing two nitrogen atoms in positions 1 and 4, as well as four carbon atoms. Piperazine is one of the most sought heterocyclics for the development of new drug candidates with a wide range of applications. Over 100 molecules with a broad range of bioactivities, including antitumor, antibacterial, anti-inflammatory, antioxidant, and other activities, were reviewed. This article reviewed investigations regarding piperazine groups for the modification of natural product derivatives in the last decade, highlighting parameters that affect their biological activity.

摘要

哌嗪部分是一种含有两个氮原子在 1 位和 4 位以及四个碳原子的环状分子。哌嗪是开发具有广泛应用的新型候选药物的最受欢迎的杂环之一。综述了 100 多种具有广泛生物活性的分子,包括抗肿瘤、抗菌、抗炎、抗氧化等活性。本文综述了过去十年中哌嗪基团对天然产物衍生物修饰的研究,强调了影响其生物活性的参数。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/cbeea7f1a7c2/IENZ_A_1931861_F0047_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/67c153d59633/IENZ_A_1931861_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/32ba9b8d6bad/IENZ_A_1931861_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/81457e1f3e4d/IENZ_A_1931861_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/16ce6ce9a733/IENZ_A_1931861_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/83e9897d3056/IENZ_A_1931861_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/3b0fb04c22d9/IENZ_A_1931861_F0006_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/d803df68f6f4/IENZ_A_1931861_F0007_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/26e528c9ab76/IENZ_A_1931861_F0008_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/90dd55818cd6/IENZ_A_1931861_F0009_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/c5b7caf6070c/IENZ_A_1931861_F0010_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/3b58d591de94/IENZ_A_1931861_F0011_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/759252959778/IENZ_A_1931861_F0012_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/bbc36c490ed7/IENZ_A_1931861_F0013_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/4db27207cc2a/IENZ_A_1931861_F0014_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/de1a4c8b302e/IENZ_A_1931861_F0015_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/4a8dd809325a/IENZ_A_1931861_F0016_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/95d86e97037f/IENZ_A_1931861_F0017_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/64248bb5fdc9/IENZ_A_1931861_F0018_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/80868342d8de/IENZ_A_1931861_F0019_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/9a00cb198c22/IENZ_A_1931861_F0020_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/11b688df44b1/IENZ_A_1931861_F0021_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/3e003b54f761/IENZ_A_1931861_F0022_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/daa5708a3de7/IENZ_A_1931861_F0023_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/d4689a47dd6a/IENZ_A_1931861_F0024_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/94644c5427c2/IENZ_A_1931861_F0025_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/fa0c6e01f886/IENZ_A_1931861_F0028_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/847388bd9c29/IENZ_A_1931861_F0029_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/f135c7e41de4/IENZ_A_1931861_F0030_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/77da94039aaa/IENZ_A_1931861_F0031_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/15a0b3118e47/IENZ_A_1931861_F0032_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/5fc656026297/IENZ_A_1931861_F0033_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/8811f82310bb/IENZ_A_1931861_F0034_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/2c2b93f37d35/IENZ_A_1931861_F0035_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/7b5882bd5660/IENZ_A_1931861_F0037_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/01de9b700d02/IENZ_A_1931861_F0040_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/3bb2b4a30a1f/IENZ_A_1931861_F0041_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/6e43988f3898/IENZ_A_1931861_F0043_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/5b358b151cd3/IENZ_A_1931861_F0044_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/60b7b208fd74/IENZ_A_1931861_F0046_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/cbeea7f1a7c2/IENZ_A_1931861_F0047_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/67c153d59633/IENZ_A_1931861_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/32ba9b8d6bad/IENZ_A_1931861_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/81457e1f3e4d/IENZ_A_1931861_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/16ce6ce9a733/IENZ_A_1931861_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/83e9897d3056/IENZ_A_1931861_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/3b0fb04c22d9/IENZ_A_1931861_F0006_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/d803df68f6f4/IENZ_A_1931861_F0007_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/26e528c9ab76/IENZ_A_1931861_F0008_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/90dd55818cd6/IENZ_A_1931861_F0009_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/c5b7caf6070c/IENZ_A_1931861_F0010_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/3b58d591de94/IENZ_A_1931861_F0011_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/759252959778/IENZ_A_1931861_F0012_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/bbc36c490ed7/IENZ_A_1931861_F0013_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/4db27207cc2a/IENZ_A_1931861_F0014_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/de1a4c8b302e/IENZ_A_1931861_F0015_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/4a8dd809325a/IENZ_A_1931861_F0016_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/95d86e97037f/IENZ_A_1931861_F0017_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/64248bb5fdc9/IENZ_A_1931861_F0018_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/80868342d8de/IENZ_A_1931861_F0019_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/9a00cb198c22/IENZ_A_1931861_F0020_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/11b688df44b1/IENZ_A_1931861_F0021_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/3e003b54f761/IENZ_A_1931861_F0022_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/daa5708a3de7/IENZ_A_1931861_F0023_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/d4689a47dd6a/IENZ_A_1931861_F0024_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/94644c5427c2/IENZ_A_1931861_F0025_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/fa0c6e01f886/IENZ_A_1931861_F0028_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/847388bd9c29/IENZ_A_1931861_F0029_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/f135c7e41de4/IENZ_A_1931861_F0030_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/77da94039aaa/IENZ_A_1931861_F0031_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/15a0b3118e47/IENZ_A_1931861_F0032_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/5fc656026297/IENZ_A_1931861_F0033_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/8811f82310bb/IENZ_A_1931861_F0034_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/2c2b93f37d35/IENZ_A_1931861_F0035_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/7b5882bd5660/IENZ_A_1931861_F0037_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/01de9b700d02/IENZ_A_1931861_F0040_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/3bb2b4a30a1f/IENZ_A_1931861_F0041_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/6e43988f3898/IENZ_A_1931861_F0043_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/5b358b151cd3/IENZ_A_1931861_F0044_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/60b7b208fd74/IENZ_A_1931861_F0046_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57a0/8183565/cbeea7f1a7c2/IENZ_A_1931861_F0047_C.jpg

相似文献

1
Piperazine skeleton in the structural modification of natural products: a review.哌嗪骨架在天然产物结构修饰中的应用:综述。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1165-1197. doi: 10.1080/14756366.2021.1931861.
2
Piperazine scaffold: A remarkable tool in generation of diverse pharmacological agents.哌嗪支架:生成多种药理活性剂的卓越工具。
Eur J Med Chem. 2015 Sep 18;102:487-529. doi: 10.1016/j.ejmech.2015.07.026. Epub 2015 Jul 18.
3
Piperazine derivatives with central pharmacological activity used as therapeutic tools.具有中枢药理活性的哌嗪衍生物用作治疗工具。
Fundam Clin Pharmacol. 2019 Feb;33(1):13-24. doi: 10.1111/fcp.12408. Epub 2018 Sep 17.
4
Synthetic Protocols, Structural Activity Relationship, and Biological Activity of Piperazine and its Derivatives.哌嗪及其衍生物的合成方案、结构活性关系和生物活性。
Med Chem. 2024;20(8):753-780. doi: 10.2174/0115734064304396240415110015.
5
The potential of marine-derived piperazine alkaloids: Sources, structures and bioactivities.海洋源哌嗪生物碱的潜力:来源、结构和生物活性。
Eur J Med Chem. 2024 Feb 5;265:116081. doi: 10.1016/j.ejmech.2023.116081. Epub 2023 Dec 26.
6
Piperazine derivatives for therapeutic use: a patent review (2010-present).用于治疗用途的哌嗪衍生物:专利综述(2010年至今)
Expert Opin Ther Pat. 2016 Jul;26(7):777-97. doi: 10.1080/13543776.2016.1189902. Epub 2016 May 31.
7
Synthesis and bioactivities of novel piperazine-containing 1,5-Diphenyl-2-penten-1-one analogues from natural product lead.基于天然产物前体的新型含哌嗪1,5-二苯基-2-戊烯-1-酮类似物的合成及生物活性
Bioorg Med Chem Lett. 2016 Apr 1;26(7):1849-53. doi: 10.1016/j.bmcl.2016.01.088. Epub 2016 Feb 13.
8
The medicinal chemistry of piperazines: A review.哌嗪类药物的化学:综述。
Chem Biol Drug Des. 2024 Jun;103(6):e14537. doi: 10.1111/cbdd.14537.
9
Isoxazole/Isoxazoline Skeleton in the Structural Modification of Natural Products: A Review.天然产物结构修饰中的异恶唑/异恶唑啉骨架:综述
Pharmaceuticals (Basel). 2023 Feb 2;16(2):228. doi: 10.3390/ph16020228.
10
Novel bis(pyrazole-benzofuran) hybrids possessing piperazine linker: Synthesis of potent bacterial biofilm and MurB inhibitors.新型双(吡唑并苯并呋喃)杂合体,具有哌嗪连接基:强效细菌生物膜和 MurB 抑制剂的合成。
Bioorg Chem. 2020 Sep;102:104094. doi: 10.1016/j.bioorg.2020.104094. Epub 2020 Jul 14.

引用本文的文献

1
Novel Hybrid Heterocycles Based on 1,4-Diphenylpiperazine Moiety: Synthesis via Hantzsch and Biginelli Reactions, Molecular Docking Simulation, and Antimicrobial Activities.基于1,4-二苯基哌嗪部分的新型杂化杂环:通过汉茨希和比吉内利反应合成、分子对接模拟及抗菌活性
ACS Omega. 2025 Aug 14;10(33):38014-38033. doi: 10.1021/acsomega.5c05245. eCollection 2025 Aug 26.
2
Synthesis of piperazine-based benzimidazole derivatives as potent urease inhibitors and molecular docking studies.基于哌嗪的苯并咪唑衍生物作为高效脲酶抑制剂的合成及分子对接研究
Sci Rep. 2025 Aug 9;15(1):29220. doi: 10.1038/s41598-025-14723-4.
3
Design, synthesis, and antimicrobial evaluation of novel 1,2,4-trizaole thioether derivatives with a 1,3,4-thiadiazole skeleton.

本文引用的文献

1
Synthesis of novel 18β-glycyrrhetinic piperazine amides displaying significant in vitro and in vivo antibacterial activities against intractable plant bacterial diseases.合成新型 18β-甘草次酸哌嗪酰胺,对难治性植物细菌性疾病具有显著的体外和体内抗菌活性。
Pest Manag Sci. 2020 Sep;76(9):2959-2971. doi: 10.1002/ps.5841. Epub 2020 Apr 27.
2
Novel piperazine-tailored ursolic acid hybrids as significant antibacterial agents targeting phytopathogens Xanthomonas oryzae pv. oryzae and X. axonopodis pv. citri probably directed by activation of apoptosis.新型哌嗪修饰的熊果酸杂合体作为针对植物病原菌稻黄单胞菌和柑橘溃疡病菌的有效抗菌剂,可能通过诱导细胞凋亡实现。
Pest Manag Sci. 2020 Aug;76(8):2746-2754. doi: 10.1002/ps.5822. Epub 2020 Apr 17.
3
具有1,3,4-噻二唑骨架的新型1,2,4-三唑硫醚衍生物的设计、合成及抗菌活性评价
RSC Adv. 2025 Aug 7;15(34):28084-28092. doi: 10.1039/d5ra04574f. eCollection 2025 Aug 1.
4
Effects of naphthoquinone scaffold-derived compounds on head and neck squamous cell carcinoma based on network pharmacology and molecular docking.基于网络药理学和分子对接的萘醌骨架衍生化合物对头颈部鳞状细胞癌的影响
Int J Clin Exp Pathol. 2025 Apr 15;18(4):130-147. doi: 10.62347/CMQJ5473. eCollection 2025.
5
Piperazine-Substituted Pyranopyridines Exhibit Antiproliferative Activity and Act as Inhibitors of HBV Virion Production.哌嗪取代的吡喃并吡啶具有抗增殖活性,并可作为乙肝病毒颗粒产生的抑制剂。
Int J Mol Sci. 2025 Apr 23;26(9):3991. doi: 10.3390/ijms26093991.
6
Investigation of anti-microbial and cytotoxic potential of Streptomyces werraensis GRS9 derived from the sediments of river Ganga.对源自恒河沉积物的韦拉链霉菌GRS9的抗菌和细胞毒性潜力的研究。
Braz J Microbiol. 2025 Jun;56(2):863-882. doi: 10.1007/s42770-025-01642-9. Epub 2025 Mar 11.
7
Synthesis and antimicrobial evaluation of a new hybrid bis-cyanoacrylamide-based-piperazine containing sulphamethoxazole moiety against rheumatoid arthritis-associated pathogens.一种含磺胺甲恶唑部分的新型双氰基丙烯酰胺基哌嗪杂化物对类风湿性关节炎相关病原体的合成及抗菌评价
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan 20. doi: 10.1007/s00210-024-03780-7.
8
Recent advances in the synthesis of antidepressant derivatives: pharmacologic insights for mood disorders.抗抑郁药衍生物合成的最新进展:情绪障碍的药理学见解
3 Biotech. 2024 Nov;14(11):260. doi: 10.1007/s13205-024-04104-5. Epub 2024 Oct 5.
9
Novel sulfonamides unveiled as potent anti-lung cancer agents tumor pyruvate kinase M2 activation.新型磺胺类药物被揭示为有效的抗肺癌药物,可激活肿瘤丙酮酸激酶M2。
RSC Med Chem. 2024 Jul 11;15(9):3070-3091. doi: 10.1039/d4md00367e. eCollection 2024 Sep 19.
10
Design, synthesis, analgesic, antibacterial and docking studies of novel 8-piperazinylcaffeine carboxylate ionic liquids.新型8-哌嗪基咖啡因羧酸盐离子液体的设计、合成、镇痛、抗菌及对接研究
RSC Adv. 2024 Sep 10;14(39):28669-28683. doi: 10.1039/d4ra06244b. eCollection 2024 Sep 4.
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019.天然产物:1981 年 1 月至 2019 年 9 月近四十年来的新药来源
J Nat Prod. 2020 Mar 27;83(3):770-803. doi: 10.1021/acs.jnatprod.9b01285. Epub 2020 Mar 12.
4
Synthesis and Cytotoxic Activity of New Vindoline Derivatives Coupled to Natural and Synthetic Pharmacophores.新型长春多灵衍生物与天然及合成药效基团偶联物的合成及细胞毒性活性
Molecules. 2020 Feb 24;25(4):1010. doi: 10.3390/molecules25041010.
5
Design, synthesis and antibacterial activities of pleuromutilin derivatives.标题:截短侧耳素衍生物的设计、合成与抗菌活性研究。
J Asian Nat Prod Res. 2021 Feb;23(2):123-137. doi: 10.1080/10286020.2020.1713764. Epub 2020 Feb 6.
6
Designing Chimeric Molecules for Drug Discovery by Leveraging Chemical Biology.利用化学生物学设计用于药物发现的嵌合分子。
J Med Chem. 2020 Mar 12;63(5):1908-1928. doi: 10.1021/acs.jmedchem.9b01456. Epub 2020 Feb 19.
7
A 18β-glycyrrhetinic acid conjugate with Vorinostat degrades HDAC3 and HDAC6 with improved antitumor effects.18β-甘草次酸与伏立诺他的缀合物可降解 HDAC3 和 HDAC6,并具有改善的抗肿瘤作用。
Eur J Med Chem. 2020 Feb 15;188:111991. doi: 10.1016/j.ejmech.2019.111991. Epub 2019 Dec 20.
8
Modification of 7-piperazinylquinolone antibacterials to promising anticancer lead compounds: Synthesis and in vitro studies.将 7-哌嗪基喹诺酮类抗菌药物进行修饰,得到有前途的抗癌先导化合物:合成与体外研究。
Eur J Med Chem. 2020 Feb 1;187:111970. doi: 10.1016/j.ejmech.2019.111970. Epub 2019 Dec 15.
9
Design, synthesis and evaluation of diosgenin carbamate derivatives as multitarget anti-Alzheimer's disease agents.薯蓣皂苷碳酰胺衍生物的设计、合成与评价及其作为多靶点抗阿尔茨海默病药物的研究。
Eur J Med Chem. 2020 Feb 1;187:111913. doi: 10.1016/j.ejmech.2019.111913. Epub 2019 Nov 28.
10
Synthesis of Combretastatin-A4 Carboxamidest that Mimic Sulfonyl Piperazines by a Molecular Hybridization Approach: in vitro Cytotoxicity Evaluation and Inhibition of Tubulin Polymerization.通过分子杂交方法合成模拟磺酰基哌嗪的康普瑞汀 A4 羧酰胺:体外细胞毒性评价和微管蛋白聚合抑制。
ChemMedChem. 2019 Dec 17;14(24):2052-2060. doi: 10.1002/cmdc.201900541. Epub 2019 Nov 13.